Clinical trial Recruiting at 1 site Interventional Ages 2 to 10

Using high-flow nasal cannula to prevent low oxygen levels during intubation in children

Official title: Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Randomized Controlled Clinical Trial

Run by Henan Provincial People's Hospital · NCT06425406 · Data updated 2026-11-12

This study is testing if using a high-flow nasal cannula can help prevent low oxygen levels in children aged 2-10 during the process of intubation for surgery.

Quick facts

Study typeInterventional
Ages2 Years to 10 Years
SexAll
Enrollment48 (estimated)
SponsorHenan Provincial People's Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Zhengzhou, Henan)
StatusRecruiting
StartedJune 15, 2024
Main results expectedNovember 30, 2025
Study endsNovember 30, 2025
Registry record updatedDecember 1, 2025
Trial IDNCT06425406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 2-10 years with healthy lungs and hearts, classified as ASA Level I or II.

Probably not a fit

Patients with upper respiratory tract infections, significant pulmonary dysfunction, or those who refuse HFNC may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of high-flow nasal cannula (HFNC) in preventing hypoxemia during the critical period of tracheal intubation in children aged 2-10 years. Given that children have unique physiological characteristics that make them more susceptible to low oxygen levels, the study aims to explore how HFNC can improve oxygenation compared to traditional methods. The trial will involve monitoring oxygen levels and respiratory function during anesthesia induction and intubation, utilizing ultrasound for additional assessment of gastric distension. The goal is to establish a safer pre-oxygenation strategy for pediatric patients undergoing surgery.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of hypoxemia and related complications during pediatric intubation.

How similar studies have gone: While there are limited studies specifically on HFNC in children during intubation, its use in adults has shown promising results, indicating potential for success in this pediatric application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 2-10 years old;
* American Society of Anesthesiologists (ASA) Level I or II;
* Children with healthy lungs and hearts;
* Clear headed and able to cooperate with anesthesiologists for treatment.

Exclusion Criteria:

* Contraindications for HFNC: (1) Complete obstruction of the upper respiratory tract; (2) Skull base fracture or nasal bone fracture; (3) Patients who refuse to use HFNC;
* The American Society of Anesthesiologists (ASA) rating is greater than Level II;
* Children with upper respiratory tract infections within 2 weeks;
* Pulmonary dysfunction, congenital heart disease in children;

Where it's running

  • Department of Anaesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital
    Zhengzhou, Henan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.